Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Health

Results: 289-300 of 8087

PR Newswire associated0

EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS

Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market

Clinigen Announces World-First Pharmaceutical Approval for Prolacta Bioscience's PreemieFort® Enteral Solution, Human Milk-Based Product in Japan

Tilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals

Business Wire logo

ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices

PR Newswire associated0

EDAN Connects Clinical Practice and Innovation at 2026 WHX Dubai and WHX Labs Dubai

PR Newswire associated0

Blackrock Health partners with RLDatix to strengthen continuity of care and operational resilience during EPR downtime

PR Newswire associated0

Berlin Heals Successfully Raises Over 10M USD to Expand the New Less Invasive Approach to More Heart Failure Patients

PR Newswire associated0

J INTS BIO Reports Fourth-Generation EGFR Inhibitor JIN-A02 in Clinical Cancer Research

PR Newswire associated0

Bracco and ACIST Medical Systems Announce European Launch of ACIST Pro™ Diagnostic System

Business Wire logo

We Are All Sculptra: First-of-its-Kind Galderma Initiative to Demonstrate How Everyone Can Benefit from Sculptra’s Regenerative Properties

PR Newswire associated0

ToolGen Enters 'Harvest Season' for Global IP Monetization; Appoints Litigation & Negotiation Expert Dave Koo as CLO

  • Prev Page
  • 1
  • 2
  • …
  • 24
  • 25
  • 26
  • …
  • 673
  • 674
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us